The effects of clozapine on cognitive functioning in treatment-resistant schizophrenic patients

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 9, Issue 2, 1997, Pages 240-245

  Fujii, Daryl E M ^b   Ahmed, Iqbal ^a   Jokumsen, Marna ^b   Compton, John M ^b  

^a Hawaii State Hospital   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; CARBAMAZEPINE; CHLORPROMAZINE; CLONAZEPAM; CLOZAPINE; DIPHENHYDRAMINE; HALOPERIDOL; LITHIUM; LORAZEPAM; LOXAPINE; NEUROLEPTIC AGENT; TIOTIXENE; VALPROATE SEMISODIUM;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; HUMAN; INTELLIGENCE QUOTIENT; MENTAL PERFORMANCE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SCHIZOPHRENIA;

EID: 0030951286     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.9.2.240     Document Type: Article

References (46)

1. Bornstein RA, Nasrallah HA, Olson SC, et al: Neuropsychological deficit in schizophrenic subtypes: paranoid, nonparanoid, and schizoaffective subgroups. Psychiatry Res 1990; 31:15-24
2. Goldberg TE, Ragland D, Torrey EF, et al: Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry 1990; 47:1066-1071
3. Dalby JT, Williams R: Preserved reading and spelling in psychotic disorders. Psychol Med 1986; 16:171-175
4. Schwartzman AE, Douglas, VI: Intellectual loss in schizophrenia, part I. Can J Psychol 1962; 16:1-10
5. Cornblatt BA, Erlenmeyer-Kimling L: Global attentional deviance as a marker of risk for schizophrenia. J Abnorm Psychol 1985; 94:470-486
6. Lane EA, Albee GA: Childhood intellectual development of adult schizophrenics. Journal of Abnormal Social Psychology 1963; 67:186-189
7. Asarnow RF, MacCrimmon D, Duncan J: Residual performance deficit in clinically remitted schizophrenics: a marker of schizophrenia. J Abnorm Psychol 1978; 87:597-608
8. Harvey PD, Serper MR: Linguistic and cognitive failures in schizophrenia: a multivariate assessment. J Nerv Ment Dis 1990; 178:487-493
9. Heaton RK, Drexler M: Clinical neuropsychological findings in schizophrenia and aging, in Schizophrenia and Aging, edited by Miller NE, Coles GD. New York, Guilford, 1987, pp 145-161
10. Martin JP, Friedmeyer MH, Sterne AL, et al: IQ deficit in schizophrenia: a test of competing theories. J Clin Psychol 1977; 33:667-672
11. Goldberg TE, Greenberg RD, Griffin SJ, et al: The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 1993; 162:43-48
12. Gold JM, Harvey PD: Cognitive deficits in schizophrenia. Psychiatr Clin North Am 1993; 16:295-312
13. Randolph C, Goldberg TE, Weinberger DR: The neuropsychology of schizophrenia, in Clinical Neuropsychology, 3rd edition, edited by Heilman KM, Valenstein E. New York, Oxford University Press, 1993, pp 499-522
14. Andreasen NC, Nasrallah HA, Dunn V, et al: Structural abnormalities in the frontal system in schizophrenia: a magnetic resonance imaging study. Arch Gen Psychiatry 1986; 43:136-144
15. Nestor PG, Shenton ME, McCarley RW, et al: Neuropsychological correlates of MRI temporal lobe abnormalities in schizophrenia. Am J Psychiatry 1993; 150:1849-1855
16. Buchsbaum MS, Haier RJ, Potkin SG, et al: Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 1992; 49:935-942
17. Gur RE, Saykin AJ: Neurobehavioral studies in schizophrenia: implications for regional brain dysfunction. Schizophr Bull 1990; 16:445-451
18. Kenny JT, Meltzer HY: Attention and higher cortical functions in schizophrenia. J Neuropsychiatry Clin Neurosci 1991; 3:269-275
19. Cummings J: Clinical Neuropsychiatry. Orlando, FL, Grune and Stratton, 1985
20. Meltzer HY, Burnett S, Bastani B, et al: Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 1990; 41:892-897
21. Kane J, Honigfeld G, Singer J, et al: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789-796
22. Meltzer H: Dimensions of outcome with clozapine. Br J Psychiatry 1992;160(17, suppl):46 -53
23. Donnelly KZ, Bellus SB, Grace J, et al: Improvements in cognitive functioning among schizophrenics treated with clozapine (abstract). The Clinical Neuropsychologist 1991; 5:267
24. Williams R, Baillie P, Dickson RA, et al: Cognitive and behavioral efficacy of clozapine in clinical trials (letter). Am J Psychiatry 1993; 38:522
25. Launer M: Clozapine, cognition, and schizophrenia (letter). Br J Psychiatry 1993; 162:567-568
26. Hagger C, Buckley P, Kenny JT, et al: Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patient receiving clozapine. Biol Psychiatry 1993; 34:702-712
27. Lee MA, Thompson PA, Meltzer HY: Effects of clozapine on cognitive functioning in schizophrenia. J Clin Psychiatry 1994; 55(suppl B):82-89
28. Bernstein JG: Handbook of Drug Therapy in Psychiatry. Littleton, MA, PSG, 1988
29. Heaton RK: The Wisconsin Card Sorting Manual. Odessa, FL, Psychological Assessment Resources, 1981
30. Reitan RM: Manual for Administration of Neuropsychological Test Batteries for Adults and Children. Tucson, AZ, Neuropsychological Press, 1985
31. Wechsler D: The Wechsler Adult Intelligence Scale-Revised. New York, Psychological Corporation, 1981
32. Neter J, Wasserman W, Kutner MH: Applied Linear Statistical Models: Regression, Analysis of Variance, and Experimental Designs. Illinois, Richard D Irwin, 1985
33. LezakMD: Neuropsychological Assessment. New York, Oxford University Press, 1983
34. Goldberg TE, Gold JM, Braff DL: Neuropsychological functioning and time-linked information processing in schizophrenia, in American Psychiatric Press Review of Psychiatry, vol 10, edited by Tasman A, Goldfinger SM. Washington, DC, American Psychiatric Press, 1991, pp 60-78
35. Wolkin A, Sanfilo M, Wolf AP, et al: Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry 1992; 49:959-965
36. Breier A, Schreiber JL, Dyer J, et al: National Institute of Mental Health longitudinal study of chronic schizophrenia. Arch Gen Psychiatry 1991; 48:239-246
37. Addington J, Addington D, Maticka-Tyndale E: Cognitive functioning and positive and negative symptoms in schizophrenia. Schizophr Res 1991; 5:123-134
38. Perlick D, Stastny P, Mattis S, et al: Contribution of family, cognitive and clinical dimensions to long-term outcome in schizophrenia. Schizophr Res 1992; 6:257-265
39. Ingraham LJ, Aiken CB: An empirical approach to determining criteria for abnormality in test batteries with multiple measures. Neuropsychology 1996; 10:120-124
40. King DJ: The effect of neuroleptics on cognitive and psychomotor function. Br J Psychiatry 1990; 157:799-811
41. Perlick D, Statsny P, Katz I, et al: Memory deficits and anticholinergic level in schizophrenia. Am J Psychiatry 1986; 143:230-232
42. Lister RG: The amnesic action of benzodiazepines in man. Neurosci Biobehav Rev 1985; 9:87-94
43. Judd L, Squire LR, Butters N, et al: Effects of psychotropic drugs on cognition and memory in normal humans and animals, in Psychopharmacology: The Third Generation of Progress, edited by Meltzer HY New York, Raven, 1987, pp 1467-1476
44. Reynolds EH: Mental effects of antiepileptic medication: a review. Epilepsia 1983; 24(suppl 2):S85-S95
45. Saletu B, Grunberger J, Linzmayer L, et al: Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry. Pharmacopsychiatry 1987; 29:12-27
46. Carter J, Thrasher S, Thornicraft G: Cognitive impairment and clozapine (letter). Br J Psychiatry 1994; 164:132-133